Baylor College of Medicine Medical Center — Houston, Texas

Baylor College of Medicine Medical Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Baylor College of Medicine Medical Center has participated in 32 clinical trials with 18 currently active.

Therapeutic areas: Thyroid Eye Disease, Non-muscle Invasive Bladder Cancer (NMIBC), Metastatic Colorectal Cancer.

Sponsors: Amgen, Anchiano Therapeutics Israel Ltd., Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Houston

Browse all research sites in Texas · View every site in Houston

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baylor College of Medicine Medical Center?

Baylor College of Medicine Medical Center has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baylor College of Medicine Medical Center conducted?

Baylor College of Medicine Medical Center has 32 clinical trials on record, with 18 currently active. Their work covers Thyroid Eye Disease, Non-muscle Invasive Bladder Cancer (NMIBC), Metastatic Colorectal Cancer.

Is Baylor College of Medicine Medical Center accredited by Crixeo Clinical Trials?

Baylor College of Medicine Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baylor College of Medicine Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.